JP2003522782A - ２−メチル−チアゾリジン−２，４−ジカルボン酸及び／又はその生理学的に許容できる塩の抗がん剤としての使用 - Google Patents

２−メチル−チアゾリジン−２，４−ジカルボン酸及び／又はその生理学的に許容できる塩の抗がん剤としての使用

Info

Publication number
JP2003522782A
JP2003522782A JP2001559441A JP2001559441A JP2003522782A JP 2003522782 A JP2003522782 A JP 2003522782A JP 2001559441 A JP2001559441 A JP 2001559441A JP 2001559441 A JP2001559441 A JP 2001559441A JP 2003522782 A JP2003522782 A JP 2003522782A
Authority
JP
Japan
Prior art keywords
thiazolidine
methyl
dicarboxylic acid
mtdc
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001559441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003522782A5 (enExample
Inventor
スシロ、ルディ
ロンメルスパシャー、ハンス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2003522782A publication Critical patent/JP2003522782A/ja
Publication of JP2003522782A5 publication Critical patent/JP2003522782A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2001559441A 2000-02-15 2001-02-15 ２−メチル−チアゾリジン−２，４−ジカルボン酸及び／又はその生理学的に許容できる塩の抗がん剤としての使用 Pending JP2003522782A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
DE10008159.2 2000-02-15
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (2)

Publication Number Publication Date
JP2003522782A true JP2003522782A (ja) 2003-07-29
JP2003522782A5 JP2003522782A5 (enExample) 2005-04-14

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001559441A Pending JP2003522782A (ja) 2000-02-15 2001-02-15 ２−メチル−チアゾリジン−２，４−ジカルボン酸及び／又はその生理学的に許容できる塩の抗がん剤としての使用

Country Status (15)

Country Link
US (2) US6943185B2 (enExample)
EP (1) EP1255538B1 (enExample)
JP (1) JP2003522782A (enExample)
CN (1) CN1400899A (enExample)
AT (1) ATE252383T1 (enExample)
AU (1) AU783933B2 (enExample)
CA (1) CA2399709C (enExample)
DE (2) DE10008159B4 (enExample)
EA (1) EA004592B1 (enExample)
ES (1) ES2208571T3 (enExample)
MX (1) MXPA02007903A (enExample)
PL (1) PL357179A1 (enExample)
PT (1) PT1255538E (enExample)
TR (1) TR200302134T4 (enExample)
WO (1) WO2001060343A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536287A (ja) * 2004-05-03 2007-12-13 ルディ・スシロ ２−メチルチアゾリジン−２，４−ジカルボン酸含有組合せ調製物
JP2009227660A (ja) * 2008-02-28 2009-10-08 Ajinomoto Co Inc システイン誘導体
JP2010001239A (ja) * 2008-06-19 2010-01-07 Nippon Rikagaku Yakuhin Kk 外用組成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
CN101838218A (zh) * 2002-02-28 2010-09-22 日本烟草产业株式会社 酯化合物及其医药用途
WO2005021486A1 (ja) * 2003-08-29 2005-03-10 Japan Tobacco Inc. エステル誘導体及びその医薬用途
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
AU2005297923B2 (en) * 2004-10-25 2010-12-23 Japan Tobacco Inc. Solid medicinal preparation improved in solubility and stability and process for producing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536287A (ja) * 2004-05-03 2007-12-13 ルディ・スシロ ２−メチルチアゾリジン−２，４−ジカルボン酸含有組合せ調製物
JP2009227660A (ja) * 2008-02-28 2009-10-08 Ajinomoto Co Inc システイン誘導体
JP2010001239A (ja) * 2008-06-19 2010-01-07 Nippon Rikagaku Yakuhin Kk 外用組成物

Also Published As

Publication number Publication date
ATE252383T1 (de) 2003-11-15
EP1255538A2 (de) 2002-11-13
AU783933B2 (en) 2005-12-22
PT1255538E (pt) 2004-03-31
EA004592B1 (ru) 2004-06-24
DE50100833D1 (de) 2003-11-27
DE10008159A1 (de) 2001-09-06
MXPA02007903A (es) 2004-09-10
EA200200853A1 (ru) 2003-02-27
DE10008159B4 (de) 2005-08-18
US20050187271A1 (en) 2005-08-25
EP1255538B1 (de) 2003-10-22
CN1400899A (zh) 2003-03-05
PL357179A1 (en) 2004-07-26
WO2001060343A3 (de) 2002-05-30
TR200302134T4 (tr) 2004-01-21
ES2208571T3 (es) 2004-06-16
WO2001060343A2 (de) 2001-08-23
AU3919001A (en) 2001-08-27
US6943185B2 (en) 2005-09-13
US20030149085A1 (en) 2003-08-07
CA2399709A1 (en) 2001-08-23
CA2399709C (en) 2007-05-15

Similar Documents

Publication Publication Date Title
JP6837835B2 (ja) トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療
WO1989000427A1 (fr) Utilisation pharmaceutique therapeutique d'un derive de glutathion
KR100949318B1 (ko) 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물
US20140120181A1 (en) Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent
JP2004502743A (ja) 薬学的化合物の還元体の製造、安定化および使用
JP2003522782A (ja) ２−メチル−チアゾリジン−２，４−ジカルボン酸及び／又はその生理学的に許容できる塩の抗がん剤としての使用
JPH11504000A (ja) 造血前駆細胞の増殖を促進するチオール類
TWI564291B (zh) 一氧化氮生成調節劑
WO2019217164A1 (en) Compositions and methods for treating cancer and other diseases
CN111346081B (zh) 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途
Prylutska et al. Comparative study of antitumor effect of pristine C60 fullerenes and doxorubicin
US9102636B2 (en) Analgesic compounds, compositions, and uses thereof
KR20080111021A (ko) 철 대사 장애의 치료를 위한 스트로빌루린의 용도
CN101060840A (zh) 核糖－半胱氨酸通过提高细胞内谷胱甘肽的送递和atp的水平以治疗缺氧的用途
EP2377529A1 (en) Use of racemates of pinocembrin in preparing medicaments for treating stroke
JP2009522257A (ja) ウイルス感染症治療用薬剤
CN112888419A (zh) 用于治疗和预防Leber遗传性视神经病变的组合物和方法
US9029419B2 (en) Use of zinc N-acetyltaurinate
JPH0859485A (ja) ３ーオキシゲルミルプロピオン酸化合物を主成分とするメイラード反応阻害剤
RU2807600C1 (ru) Антиоксидантный препарат для животных на основе водного раствора фуллерена С60, ресвератрола и альфа-липоевой кислоты
US20240150280A1 (en) Compound, agent and composition for the suppression of cancer growth
RU2715679C1 (ru) Способ снижения прооксидантного действия антиконвульсантов в эксперименте
Elshater et al. Effect of Fullerene C60 (NPs) on Cyclophosphamide-Induced Hepato and Cardiac Toxicity in Male Albino Rats.
JP4734560B2 (ja) キノン体若しくはキノン体前駆体の毒性に起因する障害に対する予防治療剤
JP2016017059A (ja) 抗腫瘍性プロドラッグを含む組成物

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070426

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070530

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20071106

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20071207

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071115

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20080201

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080409